Cox models survival analysis based on breast cancer treatments

Iranian Journal of Cancer Prevention

Volumn 7, Issue 3, 2014, Pages 124-129

  Abadi, Alireza ^a   Yavari, Parvin ^a   Dehghani Arani, Monireh ^a   Alavi Majd, Hamid ^a   Ghasemi, Erfan ^a   Amanpour, Farzaneh ^a   Bajdik, Chris ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Breast cancer; Cox PH regression; Stratified Cox model; Treatment

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT PREFERENCE; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; SURVIVAL TIME;

EID: 84907374457     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cox DR. Regression models and life-tables. Journal of Royal Statistical Society. 1972; 34(2):187-220.
2. Efron B. The efficiency of Cox's likelihood function for censored data. Journal of American Statistical association. 1977; 72:557-65.
3. Oakes D. The asymptotic information in censored survival data. Biometrika. 1977; 64:441-8.
4. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. British Journal of Cancer. 1985; 72:511-8.
5. Lawless J. Statistical Models and Methods for Lifetime Data. New York: Wiley; 1982.
6. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer; 2003.
7. Kleinbaum D, Klein M. Survival Analysis. New York: Springer; 2005.
8. Yavari P, Barroetavena M, Hislop T, Bajdik C. Breast cancer treatment and ethnicity in British Columbia, Canada. BMC Cancer. 2010; 10:154.
9. Olivotto IA, Bajdik CD, Plenderleith IH, Coppin CM, Gelmon KA, Jackson SM, et al. Adjuvant Systemic Therapy and Survival after Breast Cancer. N Engl J Med. 1994; 330:805-10.
10. Harirchi MR, Vahdani Nia, Montazeri A. 5-year survival rate in women with breast cancer in Imam Khomeini Hospital: A prospective study. Payesh. 1382; 2(2):137-42.
11. Bunderd NJ. Prognostic and predictive factors in breast cancer. Cancer Treatment Review. 2001; 27: 137-42.
12. Gizlice Z. Breast cancer incidence mortality and survival in North Carolina. www.schs.state.nc.us/SCHS/. Updated June 17, 2013.
13. KuruB, Camlibel M, Dinc S, Gulcelik MA, Gonullu D, Alagol H. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singapore Med J. 2008; 49(11):904.
14. Zhouguanghui M. D, Yexiongli M. D, Zihaoyu M. D, Zhongxingliao M.D. Survey on use of postmastecomy radiotherapy for breast cancer in china, Int. J. Radiation Oncology Biol. 2006; 66:1135-42.
15. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet. 2005; 365:1687-717.
16. Leung AM., Vu HN, Nguyen KA, Thacker LR, Harry DB. Effects of Surgical Excision on Survival of Patients with Stage IV Breast Cancer. Journal of Surgical Research. 2009; 161(1):83-88.
17. Francchia A, Evans J F, Eisenberg BL. Stage III Carcinoma of the Breast a Detailed Analysis Ann Surg. 1980; 192(6):705-10.